Clinical Trials Browser

OTHER × Pyloric Stenosis, Hypertrophic × Immunotherapy, Adoptive × Clear all

NCT04512716 2026-02-17

Iomab-ACT: A Pilot Study of 131-I Apamistamab Followed by CD19-Targeted CAR T-Cell Therapy for Patients With Relapsed or Refractory B-Cell Acute Lymphoblastic Leukemia or Diffuse Large B-Cell Lymphoma

Phase EARLY_PHASE1 Recruiting

Lymphoma, Large B-Cell, Diffuse, Pyloric Stenosis, Hypertrophic